vs
Orthofix Medical Inc.（OFIX）与全食超市（SMPL）财务数据对比。点击上方公司名可切换其他公司
全食超市的季度营收约是Orthofix Medical Inc.的1.5倍（$340.2M vs $219.9M），全食超市净利率更高（7.4% vs -1.0%，领先8.4%），Orthofix Medical Inc.同比增速更快（2.0% vs -0.3%），全食超市自由现金流更多（$48.0M vs $16.8M），过去两年Orthofix Medical Inc.的营收复合增速更高（8.0% vs 3.0%）
Orthofix医疗是全球知名骨科医疗器械企业，专注于研发、生产及销售脊柱植入物、骨科创伤产品、骨生长刺激治疗设备及再生医疗产品，服务全球多地的骨科医师与医疗机构，致力于提升肌肉骨骼疾病患者的诊疗效果。
全食超市是总部位于美国得克萨斯州奥斯汀的跨国连锁超市，现为亚马逊全资旗下品牌。门店主打无氢化脂肪、人工色素、人工香精、防腐剂的天然食品，是美国农业部认证的有机食品零售商，以丰富的有机商品选择深受消费者欢迎。
OFIX vs SMPL — 直观对比
营收规模更大
SMPL
是对方的1.5倍
$219.9M
营收增速更快
OFIX
高出2.3%
-0.3%
净利率更高
SMPL
高出8.4%
-1.0%
自由现金流更多
SMPL
多$31.2M
$16.8M
两年增速更快
OFIX
近两年复合增速
3.0%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $219.9M | $340.2M |
| 净利润 | $-2.2M | $25.3M |
| 毛利率 | 71.1% | 32.3% |
| 营业利润率 | 0.2% | 11.0% |
| 净利率 | -1.0% | 7.4% |
| 营收同比 | 2.0% | -0.3% |
| 净利润同比 | 92.4% | -33.7% |
| 每股收益（稀释后） | $-0.05 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收OFIXSMPL
| Q4 25 | $219.9M | $340.2M | ||
| Q3 25 | $205.6M | — | ||
| Q2 25 | $203.1M | $381.0M | ||
| Q1 25 | $193.6M | — | ||
| Q4 24 | $215.7M | $341.3M | ||
| Q3 24 | $196.6M | $375.7M | ||
| Q2 24 | $198.6M | $334.8M | ||
| Q1 24 | $188.6M | $312.2M |
净利润OFIXSMPL
| Q4 25 | $-2.2M | $25.3M | ||
| Q3 25 | $-22.8M | — | ||
| Q2 25 | $-14.1M | $41.1M | ||
| Q1 25 | $-53.1M | — | ||
| Q4 24 | $-29.1M | $38.1M | ||
| Q3 24 | $-27.4M | $29.3M | ||
| Q2 24 | $-33.4M | $41.3M | ||
| Q1 24 | $-36.0M | $33.1M |
毛利率OFIXSMPL
| Q4 25 | 71.1% | 32.3% | ||
| Q3 25 | 72.2% | — | ||
| Q2 25 | 68.7% | 36.4% | ||
| Q1 25 | 62.8% | — | ||
| Q4 24 | 69.0% | 38.2% | ||
| Q3 24 | 68.7% | 38.8% | ||
| Q2 24 | 67.8% | 39.9% | ||
| Q1 24 | 67.5% | 37.4% |
营业利润率OFIXSMPL
| Q4 25 | 0.2% | 11.0% | ||
| Q3 25 | -8.3% | — | ||
| Q2 25 | -7.9% | 15.6% | ||
| Q1 25 | -25.2% | — | ||
| Q4 24 | -5.3% | 16.0% | ||
| Q3 24 | -9.6% | 12.7% | ||
| Q2 24 | -12.5% | 17.6% | ||
| Q1 24 | -15.6% | 15.4% |
净利率OFIXSMPL
| Q4 25 | -1.0% | 7.4% | ||
| Q3 25 | -11.1% | — | ||
| Q2 25 | -6.9% | 10.8% | ||
| Q1 25 | -27.4% | — | ||
| Q4 24 | -13.5% | 11.2% | ||
| Q3 24 | -13.9% | 7.8% | ||
| Q2 24 | -16.8% | 12.3% | ||
| Q1 24 | -19.1% | 10.6% |
每股收益（稀释后）OFIXSMPL
| Q4 25 | $-0.05 | $0.26 | ||
| Q3 25 | $-0.57 | — | ||
| Q2 25 | $-0.36 | $0.40 | ||
| Q1 25 | $-1.35 | — | ||
| Q4 24 | $-0.76 | $0.38 | ||
| Q3 24 | $-0.71 | $0.29 | ||
| Q2 24 | $-0.88 | $0.41 | ||
| Q1 24 | $-0.95 | $0.33 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $82.0M | $194.1M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $450.0M | $1.7B |
| 总资产 | $850.6M | $2.5B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资OFIXSMPL
| Q4 25 | $82.0M | $194.1M | ||
| Q3 25 | $62.9M | — | ||
| Q2 25 | $65.6M | $98.0M | ||
| Q1 25 | $58.0M | — | ||
| Q4 24 | $83.2M | $121.8M | ||
| Q3 24 | $30.1M | $132.5M | ||
| Q2 24 | $26.4M | $208.7M | ||
| Q1 24 | $27.0M | $135.9M |
总债务OFIXSMPL
| Q4 25 | — | — | ||
| Q3 25 | $157.2M | — | ||
| Q2 25 | $157.0M | — | ||
| Q1 25 | $156.9M | — | ||
| Q4 24 | $157.0M | — | ||
| Q3 24 | $118.5M | $397.5M | ||
| Q2 24 | $118.0M | $237.7M | ||
| Q1 24 | $118.2M | $237.7M |
股东权益OFIXSMPL
| Q4 25 | $450.0M | $1.7B | ||
| Q3 25 | $442.5M | — | ||
| Q2 25 | $458.3M | $1.8B | ||
| Q1 25 | $458.3M | — | ||
| Q4 24 | $503.1M | $1.8B | ||
| Q3 24 | $525.9M | $1.7B | ||
| Q2 24 | $546.0M | $1.7B | ||
| Q1 24 | $570.3M | $1.6B |
总资产OFIXSMPL
| Q4 25 | $850.6M | $2.5B | ||
| Q3 25 | $832.6M | — | ||
| Q2 25 | $837.2M | $2.4B | ||
| Q1 25 | $823.1M | — | ||
| Q4 24 | $893.3M | $2.4B | ||
| Q3 24 | $867.9M | $2.4B | ||
| Q2 24 | $882.0M | $2.2B | ||
| Q1 24 | $906.0M | $2.1B |
负债/权益比OFIXSMPL
| Q4 25 | — | — | ||
| Q3 25 | 0.36× | — | ||
| Q2 25 | 0.34× | — | ||
| Q1 25 | 0.34× | — | ||
| Q4 24 | 0.31× | — | ||
| Q3 24 | 0.23× | 0.23× | ||
| Q2 24 | 0.22× | 0.14× | ||
| Q1 24 | 0.21× | 0.14× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $27.7M | $50.1M |
| 自由现金流经营现金流 - 资本支出 | $16.8M | $48.0M |
| 自由现金流率自由现金流/营收 | 7.6% | 14.1% |
| 资本支出强度资本支出/营收 | 4.9% | 0.6% |
| 现金转化率经营现金流/净利润 | — | 1.98× |
| 过去12个月自由现金流最近4个季度 | $-1.3M | $223.6M |
8季度趋势，按日历期对齐
经营现金流OFIXSMPL
| Q4 25 | $27.7M | $50.1M | ||
| Q3 25 | $12.4M | — | ||
| Q2 25 | $11.6M | $101.1M | ||
| Q1 25 | $-18.4M | — | ||
| Q4 24 | $23.7M | $32.0M | ||
| Q3 24 | $11.7M | $48.9M | ||
| Q2 24 | $9.0M | $72.8M | ||
| Q1 24 | $-18.6M | $46.5M |
自由现金流OFIXSMPL
| Q4 25 | $16.8M | $48.0M | ||
| Q3 25 | $2.5M | — | ||
| Q2 25 | $4.5M | $98.9M | ||
| Q1 25 | $-25.1M | — | ||
| Q4 24 | $15.2M | $31.7M | ||
| Q3 24 | $6.3M | $45.0M | ||
| Q2 24 | $-360.0K | $72.0M | ||
| Q1 24 | $-29.1M | $46.1M |
自由现金流率OFIXSMPL
| Q4 25 | 7.6% | 14.1% | ||
| Q3 25 | 1.2% | — | ||
| Q2 25 | 2.2% | 25.9% | ||
| Q1 25 | -13.0% | — | ||
| Q4 24 | 7.0% | 9.3% | ||
| Q3 24 | 3.2% | 12.0% | ||
| Q2 24 | -0.2% | 21.5% | ||
| Q1 24 | -15.4% | 14.8% |
资本支出强度OFIXSMPL
| Q4 25 | 4.9% | 0.6% | ||
| Q3 25 | 4.8% | — | ||
| Q2 25 | 3.5% | 0.6% | ||
| Q1 25 | 3.5% | — | ||
| Q4 24 | 4.0% | 0.1% | ||
| Q3 24 | 2.7% | 1.0% | ||
| Q2 24 | 4.7% | 0.2% | ||
| Q1 24 | 5.6% | 0.1% |
现金转化率OFIXSMPL
| Q4 25 | — | 1.98× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 2.46× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.84× | ||
| Q3 24 | — | 1.67× | ||
| Q2 24 | — | 1.76× | ||
| Q1 24 | — | 1.40× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
OFIX
| Spinal Implants Biologics And Enabling Technologies | $113.6M | 52% |
| Bone Growth Therapies | $68.3M | 31% |
| Other | $22.7M | 10% |
| IT | $5.9M | 3% |
| GB | $3.5M | 2% |
| FR | $3.5M | 2% |
| DE | $2.3M | 1% |
SMPL
| Quest | $211.4M | 62% |
| Atkins Domain | $79.7M | 23% |
| OWYN | $28.1M | 8% |
| Other | $20.9M | 6% |
